Response to 'Simple jugular venous assessment: a new approach to heart failure'
- PMID: 40552676
- PMCID: PMC12450750
- DOI: 10.1002/ehf2.15355
Response to 'Simple jugular venous assessment: a new approach to heart failure'
Conflict of interest statement
GHDV has nothing to disclose. The employer of AAV received consultancy fees and/or research support from Adrenomed, AnaCardio, AstraZeneca, Bayer AG, BMS, Boehringer Ingelheim, Corteria, Eli Lilly, Merck, Moderna, Novartis, Novo Nordisk, Roche Diagnostics and Salubris Bio. KD reports speaker and consultancy fees from Boehringer Ingelheim, AstraZeneca, Abbott, FIRE1 and Echosense. JMtM reports speaker and/or consultancy fees from Novartis, Bayer, Boehringer Ingelheim, Johnson & Johnson, Moderna, Roche and Novo Nordisk and receives grants from the Dutch Heart Foundation and Netherlands Organisation for Scientific Research (NWO) outside the submitted work.
References
-
- Vaidya Y, Bhatti H, Dhamoon AS. Hepatojugular reflux 2025. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
